A detailed history of Weil Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Weil Company, Inc. holds 6,434 shares of ABT stock, worth $658,391. This represents 0.31% of its overall portfolio holdings.

Number of Shares
6,434
Previous 6,434 -0.0%
Holding current value
$658,391
Previous $708,000 3.25%
% of portfolio
0.31%
Previous 0.32%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $9,553 - $11,462
-100 Reduced 1.53%
6,434 $623,000
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $12,642 - $14,832
-133 Reduced 1.99%
6,534 $717,000
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $1,451 - $1,680
-15 Reduced 0.22%
6,667 $645,000
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $1,531 - $1,850
15 Added 0.22%
6,682 $726,000
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $7,069 - $8,620
-62 Reduced 0.92%
6,667 $789,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $5,133 - $5,678
-44 Reduced 0.65%
6,729 $795,000
Q2 2021

Jul 20, 2021

SELL
$105.79 - $124.53 $10,473 - $12,328
-99 Reduced 1.44%
6,773 $785,000
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $1,088 - $1,282
10 Added 0.15%
6,872 $824,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $3,769 - $5,511
-60 Reduced 0.87%
6,862 $541,000
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $36,585 - $40,728
-466 Reduced 6.31%
6,922 $601,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $221,459 - $240,130
-2,706 Reduced 26.81%
7,388 $618,000
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $4,372 - $5,100
60 Added 0.6%
10,094 $849,000
Q3 2018

Nov 07, 2018

BUY
$60.81 - $73.36 $1,337 - $1,613
22 Added 0.22%
10,034 $736,000
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $157,893 - $178,517
2,806 Added 38.94%
10,012 $600,000
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $386,818 - $414,128
7,206
7,206 $411,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Weil Company, Inc. Portfolio

Follow Weil Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Weil Company, Inc. with notifications on news.